Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular ...

Drugs like Ozempic and Mounjaro are known to lower the risk of heart attack and stroke, but a new study suggests those ...

A major study suggests that the cardiovascular benefits of certain diabetes medications can fade within months after stopping ...

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...

The medications may help prevent further tissue damage after a heart attack (myocardial infarction), according to a new study ...

Cardiac patients who need life-saving surgical treatment can be heartened by the technological advances that let them live ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

Medicare beneficiaries with heart disease or major cardiovascular risk factors reported less cost-related medication ...